Type-Specific Epitope Locations Revealed by X-Ray Crystallographic Study of Adenovirus Type 5 Hexon

Molecular Therapy

Volumn 1, Issue 1, 2000, Pages 18-30

  Rux, John J ^a   Burnett, Roger M ^a  

^a WISTAR INSTITUTE   (United States)

Author keywords

Adenovirus; epitopes; gene therapy; hexon; X ray diffraction

Indexed keywords

CAPSID PROTEIN; EPITOPE; HEXON CAPSID PROTEIN, ADENOVIRUS; HYBRID PROTEIN; VIRUS ANTIGEN;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DESIGN; GENE THERAPY; GENE VECTOR; GENETICS; HUMAN; HUMAN ADENOVIRUS; IMMUNOLOGY; PROTEIN CONFORMATION; PROTEIN ENGINEERING; PROTEIN QUATERNARY STRUCTURE; VIRUS CAPSID; X RAY CRYSTALLOGRAPHY;

ADENOVIRUSES, HUMAN; ANTIGENS, VIRAL; CAPSID; CAPSID PROTEINS; CRYSTALLOGRAPHY, X-RAY; DRUG DESIGN; EPITOPES; GENE THERAPY; GENETIC VECTORS; HUMANS; MODELS, MOLECULAR; PROTEIN CONFORMATION; PROTEIN ENGINEERING; PROTEIN STRUCTURE, QUATERNARY; RECOMBINANT FUSION PROTEINS;

EID: 0033661024     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.1999.0001     Document Type: Article

References (64)

1. Ádám É., Nász I., Hudecz F., Lengyel A., Mezö G., Dobay O. Characterization of intertype specific epitopes on adenovirus hexons. Arch. Virol. 143:1998;1669-1682.
2. Aleström P., Stenlund A., Li P., Pettersson U. A common sequence in the inverted terminal repetitions of human and avian adenoviruses. Gene. 18:1982;193-197.
3. Athappilly F. K., Murali R., Rux J. J., Cai Z., Burnett R. M. The refined crystal structure of hexon, the major coat protein of adenovirus type 2, at 2.9 Å resolution. J. Mol. Biol. 242:1994;430-455.
4. Bailey A., Mautner V. Phylogenetic relationships among adenovirus serotypes. Virology. 205:1994;438-452.
5. Benson S. D., Bamford J. K. H., Bamford D. H., Burnett R. M. Viral evolution revealed by bacteriophage PRD1 and human adenovirus coat protein structures. Cell. 98:1999;825-833.
6. Bergelson J. M., Cunningham J. A., Droguett G., Kurt-Jones E. A., Krithivas A., Hong J. S., Horwitz M. S., Crowell R. L., Finberg R. W. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science. 275:1997;1320-1323.
7. Blum M., Metcalf P., Harrison S. C., Wiley D. C. A system for collection and on-line integration of X-ray diffraction data from a multiwire area detector. J. Appl. Crystallogr. 20:1987;235-242.
8. Brünger A. T. Free R value: A novel statistical quantity for assessing the accuracy of crystal structures. Nature. 355:1992;472-475.
9. Butcher S. J., Bamford D. H., Fuller S. D. DNA packaging orders the membrane of bacteriophage PRD1. EMBO J. 14:1995;6078-6086.
10. Cepko C. L., Sharp P. A. Assembly of adenovirus major capsid protein is mediated by a nonvirion protein. Cell. 31:1982;407-415.
11. Chroboczek J., Bieber F., Jacrot B. The sequence of the genome of adenovirus type 5 and its comparison with the genome of adenovirus type 2. Virology. 186:1992;280-285.
12. Collaborative Computational Project Number 4. The CCP4 Suite: Programs for protein crystallography. Acta Crystallogr. D50:1994;760-763.
13. Cornick G., Sigler P. B., Ginsberg H. S. Characterization of crystals of type 5 adenovirus hexon. J. Mol. Biol. 57:1971;397-401.
14. Crawford-Miksza L., Schnurr D. P. Analysis of 15 adenovirus hexon proteins reveals the location and structure of seven hypervariable regions containing serotype-specific residues. J. Virol. 70:1996;1836-1844.
15. Crompton J., Toogood C. I., Wallis N., Hay R. T. Expression of a foreign epitope on the surface of the adenovirus hexon. J. Gen. Virol. 75:1994;133-139.
16. Eiz B., Adrian T., Pring-Åkerblom P. Immunological adenovirus variant strains of subgenus D: Comparison of the hexon and fiber sequences. Virology. 213:1995;313-320.
17. Evans S. V. SETOR: Hardware lighted three-dimensional solid model representations of macromolecules. J. Mol. Graph. 11:1993;134-138.
18. Franklin R. M., Pettersson U., Åkervall K., Strandberg B., Philipson L. Structural proteins of adenovirus. V. Size and structure of the adenovirus type 2 hexon. J. Mol. Biol. 57:1971;383-395.
19. Gall J. G. D., Crystal R. G., Falck-Pedersen E. Construction and characterization of hexon-chimeric adenoviruses: Specification of adenovirus serotype. J. Virol. 72:1998;10260-10264.
20. Gall J., Kass-Eisler A., Leinwand L., Falck-Pedersen E. Adenovirus type 5 and 7 capsid chimera: Fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes. J. Virol. 70:1996;2116-2123.
21. Ginsberg H. S. The Adenoviruses. 1984;Plenum, New York.
22. Hierholzer J. C., Stone Y. O., Broderson J. R. Antigenic relationships among the 47 human adenoviruses determined in reference horse antisera. Arch. Virol. 121:1991;179-197.
23. Hobohm U., Sander C. Enlarged representative set of protein structures. Protein Sci. 3:1994;522-524.
24. Hong S. S., Karayan L., Tournier J., Curiel D. T., Boulanger P. A. Adenovirus type 5 fiber knob binds to MHC class I α2 domain at the surface of human epithelial and B lymphoblastoid cells. EMBO J. 16:1997;2294-2306.
25. Horne R. W., Brenner S., Waterson A. P., Wildy P. The icosahedral form of an adenovirus. J. Mol. Biol. 1:1959;84-86.
26. Hutchinson E. G., Thornton J. M. PROMOTIF - A program to identify and analyze structural motifs in proteins. Protein Sci. 5:1996;212-220.
27. Jones T. A., Zou J.-Y., Cowan S. W., Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A47:1991;110-119.
28. Jörnvall H., Philipson L. Limited proteolysis and a reactive cysteine residue define accessible regions in the native conformation of the adenovirus hexon protein. Eur. J. Biochem. 104:1980;237-247.
29. Kabsch W. Evaluation of single-crystal X-ray diffraction data from a position-sensitive detector. J. Appl. Crystallogr. 21:1988;916-924.
30. Kass-Eisler A., Leinwand L., Gall J., Bloom B., Falck-Pedersen E. Circumventing the immune response to adenovirus-mediated gene therapy. Gene Ther. 3:1996;154-162.
31. Kinloch R., Mackay N., Mautner V. Adenovirus hexon: Sequence comparison of subgroup C serotypes 2 and 5. J. Biol. Chem. 259:1984;6431-6436.
32. Kozarsky K. F., Wilson J. M. Gene therapy: Adenovirus vectors. Curr. Opin. Genet. Dev. 3:1993;499-503.
33. Kraulis P. J. MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24:1991;946-950.
34. Li Q.-G., Lindman K., Wadell G. Hydropathic characteristics of adenovirus hexons. Arch. Virol. 142:1997;1307-1322.
35. Maizel J. V. Jr., White D. O., Scharff M. D. The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12. Virology. 36:1968;115-125.
36. Mastrangeli A., Harvey B. G., Yao J., Wolff G., Kovesdi I., Crystal R. G., Falck-Pedersen E. "Sero-switch" adenovirus-mediated in vivo gene transfer: Circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype. Hum. Gene Ther. 7:1996;79-87.
37. Merritt E. A., Bacon D. J. Raster3D: Photorealistic molecular graphics. Methods Enzymol. 277:1997;505-524.
38. Norrby E. The structural and functional diversity of adenovirus capsid components. J. Gen. Virol. 5:1969;221-236.
39. Olson A. J., Bricogne G., Harrison S. C. Structure of tomato bushy stunt virus IV. The virus particle at 2.9 Å resolution. J. Mol. Biol. 171:1983;61-93.
40. Pannu N. S., Read R. J. Improved structure refinement through maximum likelihood. Acta Crystallogr. A52:1996;659-668.
41. Pereira H. G., Valentine R. C., Russell W. C. Crystallization of an adenovirus protein (the hexon). Nature. 219:1968;946-947.
42. Pring-Åkerblom P., Adrian T. The hexon genes of adenoviruses of subgenus C: Comparison of the variable regions. Res. Virol. 144:1993;117-127.
43. Pring-Åkerblom P., Trijssenaar F. E., Adrian T. Sequence characterization and comparison of human adenovirus subgenus B and E hexons. Virology. 212:1995;232-236.
44. Ramachandran G. N., Sasisekharan V. Conformation of polypeptides and proteins. Adv. Protein Chem. 23:1968;283-438.
45. Roberts M. M., White J. L., Grütter M. G., Burnett R. M. Three-dimensional structure of the adenovirus major coat protein hexon. Science. 232:1986;1148-1151.
46. Rodriguez E., Everitt E. Adenovirus uncoating and nuclear establishment are not affected by weak base amines. J. Virol. 70:1996;3470-3477.
47. Rowe W. P., Huebner R. J., Gillmore L. K., Parrott R. H., Ward T. G. Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proc. Soc. Exp. Biol. Med. 84:1953;570-573.
48. Roy S., Shirley P. S., McClelland A., Kaleko M. Circumvention of immunity to the adenovirus major coat protein hexon. J. Virol. 72:1998;6875-6879.
49. Rux J. J., Pascolini D., Burnett R. M. Wold W. S. M. Large-Scale Purification and Crystallization of Adenovirus Hexon. 1998;259-275 Humana Press, Totowa.
50. Savilahti H., Bamford D. H. Linear DNA replication: Inverted terminal repeats of five closely related Escherichia coli bacteriophages. Gene. 49:1986;199-205.
51. Shenk T. Fields B. N., Knipe D. M., Howley P. M. Virology. 1996;2111-2148 Raven Press, New York.
52. Silva A. M., Rossmann M. G. Refined structure of southern bean mosaic virus at 2.9 Å resolution. J. Mol. Biol. 197:1987;69-87.
53. Stewart P. L., Burnett R. M., Cyrklaff M., Fuller S. D. Image reconstruction reveals the complex molecular organization of adenovirus. Cell. 67:1991;145-154.
54. Stewart P. L., Fuller S. D., Burnett R. M. Difference imaging of adenovirus: Bridging the resolution gap between X-ray crystallography and electron microscopy. EMBO J. 12:1993;2589-2599.
55. Swenson P. D., Lowens M. S., Celum C. L., Hierholzer J. C. Adenovirus types 2, 8, and 37 associated with genital infections in patients attending a sexually transmitted disease clinic. J. Clin. Microbiol. 33:1995;2728-2731.
56. Toogood C. I., Crompton J., Hay R. T. Antipeptide antisera define neutralizing epitopes on the adenovirus hexon. J. Gen. Virol. 73:1992;1429-1435.
57. Tronrud D. E., Eyck L. T., Matthews B. W. An efficient general-purpose least-squares refinement program for macromolecular structures. Acta Crystallogr. A43:1987;489-501.
58. van Oostrum J., Burnett R. M. Molecular composition of the adenovirus type 2 virion. J. Virol. 56:1985;439-448.
59. Varga M. J., Bergman T., Everitt E. Antibodies with specificities against a dispase-produced 15-kilodalton hexon fragment neutralize adenovirus type 2 infectivity. J. Virol. 64:1990;4217-4225.
60. Vigne E., Mahfouz I., Dedieu J.-F., Brie A., Perricaudet M., Yeh P. RGD inclusion in the hexon monomer provides adenovirus type 5-based vectors with a fiber knob-independent pathway for infection. J. Virol. 73:1999;5156-5161.
61. 5 promote adenovirus internalization but not virus attachment. Cell. 73:1993;309-319.
62. Wohlfart C. Neutralization of adenoviruses: Kinetics, stoichiometry, and mechanisms. J. Virol. 62:1988;2321-2328.
63. Yang Y., Li Q., Ertl H. C. J., Wilson J. M. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69:1995;2004-2015.
64. Yei S., Mittereder N., Tang K., O'Sullivan C., Trapnell B. C. Adenovirus-mediated gene transfer for cystic fibrosis: Quantitative evaluation of repeated in vivo vector administration to the lung. Gene Ther. 1:1994;192-200.